SafeCare

26/06/2025

22/06/2025

BAQSIMI® (BAK-see-mee) is used to treat very low blood sugar (severe hypoglycemia) in people with diabetes ages 4 years and above.

It is not known if BAQSIMI is safe and effective in children under 4 years of age.

06/05/2025

The focal theme for World Hand Hygiene Day in 2025 is "It might be gloves, it's always hand hygiene." This theme underscores the critical importance of diligent hand hygiene practices, even in circumstances where gloves are employed. It serves to emphasize that the use of gloves should not be considered a substitute for, but rather an adjunct to, effective hand hygiene protocols.

29/03/2025

As part of an organ donor drawing competition, Deepika, a 2nd-year MBBS student at MMC, created this artwork. Zoom in to appreciate the thoughtfulness!

27/02/2025

If you are planning to fast during Ramadan, it is crucial to consult your doctor beforehand to assess if fasting is safe for you and to create a proper management plan.
Key points to discuss with your doctor:

• Symptoms and tests: Discuss symptoms of both low blood sugar (hypoglycemia) and high blood sugar (hyperglycemia). Ensure you undergo necessary pre-Ramadan tests like retinal screening, kidney function tests, and urine protein checks.
• Blood sugar monitoring: Develop a personalized plan to monitor your blood sugar levels regularly throughout Ramadan using a glucose meter or continuous glucose monitoring (CGM) device to prevent dangerous spikes or drops.
• Medication adjustments: Understand which medications need to be taken at Sehri (pre-dawn meal) and which at Iftar (evening meal). Discuss potential dosage adjustments based on your fasting schedule.
• Diet management: Plan a balanced diet for both Sehri and Iftar, including complex carbohydrates, lean protein, healthy fats, and ample fiber to maintain stable energy levels.
• Hydration: Discuss strategies to stay hydrated during fasting hours, especially during hot weather.
• Potential complications: Discuss any concerns you may have about managing existing health conditions like diabetes, high blood pressure, or heart disease while fasting.

22/02/2025

RSSDI Kerala Annual Conference 2025 - an academic festival to Enrich, Empower and Educate..

20/02/2025

07/01/2025

*Diabetes Breakthrough: New Treatment Eliminates Insulin for 86% of Patients*

This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of insulin therapy for 86% of patients.

ReCET is a novel endoscopic procedure that uses electroporation to induce cellular apoptosis and subsequent reepithelization.

These results suggest that ReCET is feasible and safe. In combination with semaglutide, ReCET may be a promising therapeutic option to replace insulin therapy in selected T2D patients while improving glycemic control and metabolic health.

09/12/2024

Most awaited
ADA Standards of Care in Diabetes 2025 are now available!
Read the latest guidelines here:

Diabetes Care is a journal for the health care practitioner that is intended to increase knowledge, stimulate research, and promote better management of people with diabetes.